SPACE PROVIDED. Many key processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs). Abnormal regulation of such pathways can lead to developmental defects and diseases such as cancer. Understanding cellular regulation requires defining the relevant PTKs and PTPs and their interactions. This in tum may lead to new, more selective drugs for human disease. The goal of our research is to understand the biological function, mechanism of action, and role in disease ofthe PTPs Shp2 and PTPIB. Shp2, encoded by PTPNU, is required for vertebrate development and is a positive (signal-enhancing) component in growth factor, cytokine and integrin signaling. Autosomal dominant PTPNU mutations cause half of Noonan syndrome (NS) and nearly all LEOPARD syndrome (LS). NS and LS are """"""""neurocardiofacial cutaneous'(NCFC) syndromes, other examples of which include cardiofacial cutaneous syndrome (CFC), caused by BRAF or MEKl/2 mutations, and Costello Syndrome, caused by HRAS mutations. Most ofthe genes that cause NCFC syndromes are oncogenes, and most NCFC associated with cancer predisposition;Notably, somatic PTPNU mutations contribute to leukemias. Dxuing the initial years ofthis MERIT award, we characterized the properties of NS-associated Shp2 mutants and also found that, in contrast to the prevailing view, LS mutants are catalytically impaired, dominant negative alleles. We established thefirstmouse models for NS, delineated a key pathway by which Shp2 controls Ras activation, and identified the Ras exchange factor, SOSl as another major NS gene. In impublished, preliminary studies, we have identified a new, phosphatase activity-independent role for Shp2 in control of a p53-dependent cell death pathway, a pathwaytfiatmay help explain LS pathogenesis. PTPIB, in contrast, is typically a negative regulator of cell signaling. Surprisingly, however, we found that it is required for Neu-induced breast cancer. In the extension period, we will continue to use a combined genetic and ?- biochemical approach to understanding the detailed mechanism imderlying NCFC syndromes and the role of PTPIB in breast carcinogenesis. We will complete generation of mouse models for other NS genes and for CFC. We will define the Shp2 """"""""phcsphotyrosyl proteome"""""""" and the new, activity-independent pathway controlling cell death. Finally, we will elucidate the detailied mechanism by which PITIB contributes to breast carcinogenesis, and assess whether thesefindingsextend to human HER2+ breast cancer. Oiu"""""""" results should be directly relevant to uiiderstanding the pathogenesis of human NCFC syndromes and cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37CA049152-21
Application #
7754773
Study Section
Special Emphasis Panel (NSS)
Program Officer
Yassin, Rihab R,
Project Start
1988-12-01
Project End
2014-01-31
Budget Start
2009-03-01
Budget End
2010-01-31
Support Year
21
Fiscal Year
2009
Total Cost
$337,930
Indirect Cost
Name
University Health Network
Department
Type
DUNS #
208469486
City
Toronto
State
ON
Country
Canada
Zip Code
M5 2-M9
Wang, Lijun; Iorio, Caterina; Yan, Kevin et al. (2018) A ERK/RSK-mediated negative feedback loop regulates M-CSF-evoked PI3K/AKT activation in macrophages. FASEB J 32:875-887
Gu, S; Sayad, A; Chan, G et al. (2018) SHP2 is required for BCR-ABL1-induced hematologic neoplasia. Leukemia 32:203-213
Tsutsumi, Ryouhei; Harizanova, Jana; Stockert, Rabea et al. (2017) Assay to visualize specific protein oxidation reveals spatio-temporal regulation of SHP2. Nat Commun 8:466
Yao, Zhong; Darowski, Katelyn; St-Denis, Nicole et al. (2017) A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. Mol Cell 65:347-360
Zhang, Xiaoling; Dong, Zhiwei; Zhang, Cheng et al. (2017) Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation. Cell Rep 18:2932-2942
Banh, Robert S; Iorio, Caterina; Marcotte, Richard et al. (2016) PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia. Nat Cell Biol 18:803-813
Gu, Shengqing; Chan, Wayne W; Mohi, Golam et al. (2016) Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1. Blood 127:1803-13
Dodd, Garron T; Decherf, Stephanie; Loh, Kim et al. (2015) Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell 160:88-104
Chiappini, Franck; Catalano, Karyn J; Lee, Jennifer et al. (2014) Ventromedial hypothalamus-specific Ptpn1 deletion exacerbates diet-induced obesity in female mice. J Clin Invest 124:3781-92
Gurzov, Esteban N; Tran, Melanie; Fernandez-Rojo, Manuel A et al. (2014) Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2. Cell Metab 20:85-102

Showing the most recent 10 out of 76 publications